PET/CT (Oncological & Non-Oncological)
Advanced molecular imaging delivering early detection, precise staging, and comprehensive whole-body evaluation
PET/CT for Comprehensive Cancer Detection & Staging
Positron Emission Tomography–Computed Tomography (PET/CT) combines metabolic imaging with high-resolution anatomical detail, enabling early and accurate cancer detection. It identifies malignant lesions based on abnormal glucose uptake, even before structural changes appear on CT or MRI. PET/CT is critical in staging cancers such as lung, breast, lymphoma, head & neck, colorectal, and melanoma. By mapping disease extent with precision, it helps clinicians choose the most effective treatment pathway and avoid unnecessary interventions.
PET/CT in Treatment Response & Recurrence Evaluation
PET/CT is the most reliable imaging modality for assessing how well a tumor responds to therapy. It differentiates active disease from post-treatment changes such as fibrosis, scarring, or necrosis—something conventional imaging often cannot do. By comparing standardized uptake values (SUV), clinicians can adjust chemoradiation plans, change treatment regimens, or escalate therapy when necessary. It is equally valuable in detecting early recurrence, allowing timely management and significantly improving long-term outcomes.
PET/CT for Non-Oncological Disorders: Inflammation, Infection & Neurology
Beyond oncology, PET/CT plays a crucial role in diagnosing complex inflammatory and infectious conditions—including vasculitis, fever of unknown origin (FUO), prosthetic joint infections, and cardiac infections. In neurology, PET/CT aids in evaluating dementia subtypes, epilepsy focus localization, and neurodegenerative disorders. By providing metabolic insights into tissues and organs, PET/CT helps clinicians reach diagnoses that are often missed with routine scans, leading to more targeted and effective treatment approaches.
PET/CT for Precision Diagnosis & Early Disease Detection
High-sensitivity metabolic imaging that reveals abnormalities before structural changes appear
Detects early cancerous activity based on altered glucose metabolism (FDG uptake)
Identifies disease even when CT/MRI findings are normal or indeterminate
Differentiates benign, malignant, and inflammatory lesions with superior metabolic insight
Helps diagnose hidden primary tumors, especially in metastatic presentations
Enhances diagnostic certainty in complex or atypical clinical scenarios
PET/CT in Treatment Planning, Monitoring & Prognostic Assessment
Dynamic evaluation of tumor response that guides therapy adjustments and improves outcomes
Measures treatment effectiveness using standardized uptake value (SUV) trends
Distinguishes active tumor tissue from post-therapy fibrosis, necrosis, or scarring
Determines suitability for surgery, radiotherapy planning, or systemic therapy escalation
Enables early detection of non-responders, allowing timely modification of therapy
Provides prognostic markers based on metabolic burden and tumor heterogeneity
PET/CT for Non-Oncological Applications: Infection, Inflammation & Neurological Disorders
A versatile imaging modality for complex conditions beyond cancer care
Detects inflammatory activity in vasculitis, sarcoidosis, autoimmune disorders, and FUO
Maps infection spread in osteomyelitis, prosthetic joint infections, and postoperative complications
Assists in diagnosing dementia subtypes, Parkinsonian syndromes, and seizure foci
Evaluates myocardial viability and identifies cardiac inflammation such as cardiac sarcoidosis
Supports whole-body assessment in systemic diseases that require metabolic mapping
Why Choose Us
Excellence in Advanced Nuclear Medicine, Precision Imaging, and Targeted Therapies
Precision-driven nuclear imaging ensuring unmatched diagnostic clarity and confidence
Advanced theranostics delivering targeted, personalized cancer treatment solutions
Expert-led clinical care prioritizing safety, accuracy, and patient well-being
Comprehensive services covering oncology, cardiology, and functional imaging needs
Decades of experience supported by global research, leadership, and innovation
Our Expert Doctors
Dr. Gayana Shankaramurthy
